Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-12-27: Form 6-K; Period of report 2021-12-27; Description FORM 6-K; Document form6k-122721.htm.
- 2021-12-16: Form 6-K; Period of report 2021-12-16; Description FORM 6-K; Document form6k-121621.htm.
- 2021-12-14: Form 6-K; Period of report 2021-12-14; Description FORM 6-K; Document form6k-121421.htm.
- 2021-12-01: Form 6-K; Period of report 2021-12-01; Description FORM 6-K; Document form6k-120121.htm.